Clinical trial reports

Which European sites lead RNA Phase I–II trial activity in 2024–2026?
Which Endpoints Are Measured Most Often in European Respiratory Phase II and Phase III Trials?
Which EU/EEA sites lead nephrology Phase II–III trials in CTIS?
Which endpoints dominate European Phase II and III colorectal cancer trials?
Which CROs Are Most Active in European Oncology Phase III Trials, and Where Is CRO Support Needed Most?
How Fast Are CTIS Approvals and What Delays Phase I Haematology Trials?
Which EU/EEA sites lead IBD phase II–III trials, and where are patients concentrated?
Which CROs Are Most Active in Obesity Phase II and III Trials in Europe?
Which CROs Are Most Active in European Hepatocellular Cancer Phase 2 & 3 Trials?
Which Endpoints Are Measured Most Often in European Phase II & III Ovarian Cancer Trials?
Which CROs Support Colorectal Cancer Phase II/III Trials in Europe, and When Are They Used Most?
Is Overall Survival Still the Endpoint Anchor in European Phase III Lung Cancer Trials?